SCHEMBL7110629

SCHEMBL7110629

COc1ccc(C2CSC(N)=N2)cc1.NC1=NC(c2cccc(Br)c2)CS1.NC1=NC(c2ccccc2)CS1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
MAPT P10636 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MAPK1 P28482 1/20 0.37
KDM1A O60341 3/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
BACE1 P56817 2/20 0.35
RORC P51449 1/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
HDAC4 P56524 1/20 0.34
TAAR1 Q96RJ0 1/20 0.34
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7109309 0.98 KDM1A (0.38) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL7112812 0.86 HDAC3 (0.33) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL7110961 0.86 HDAC3 (0.33) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL6254097 0.85 KDM1A (0.49) ALDH1A1MAPTRAB9AKDM1AL3MBTL1
SCHEMBL6254095 0.85 KDM1A (0.49) ALDH1A1MAPTRAB9AKDM1AL3MBTL1
Hydrochloric Acid SCHEMBL7570112 0.84 KDM1A (0.50) ALDH1A1MAPTRAB9AKDM1AL3MBTL1
Hydrochloric Acid SCHEMBL7570105 0.84 KDM1A (0.50) ALDH1A1MAPTRAB9AKDM1AL3MBTL1
SCHEMBL6258048 0.83 KDM1A (0.47) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL6254714 0.83 KDM1A (0.47) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL7109313 0.82 ALDH1A1 (0.38) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1299103-A1 4,5-DIHYDRO-THIAZO-2-YLAMINE DERIVATIVES AND THEIR USE AS NO-SYNTHASE INHIBITORS Aventis Pharma S.A. (FR) 2003-04-09 EP claimed
WO-2001093867-A1 4,5-DIHYDRO-THIAZO-2-YLAMINE DERIVATIVES AND THEIR USE AS NO-SYNTHASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2001-12-13 WO claimed